Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

NCT02136940 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma
Ocular Hypertension
Eye Disease

Interventions

DRUG: AMA0076
DRUG: Placebo

Sponsor

Amakem, NV